Interventional Radiology Market By Imaging Modalities 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Interventional Radiology Market
Interventional Radiology Market: By Imaging Modalities (Fluoroscopy, Computed Tomography, Ultrasound), By Application (Vascular, Neurologic, Spine), By Procedures (Angiography, Cholecystostomy, Zmbolization) and Geography-Forecast (2016-2021)
Report Code : HCR 0231
Updated Date: 23 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Interventional Radiology – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Interventional Radiology – Market Forces
   4.1. Drivers
      4.1.1. Increasing popularity of minimally invasive procedures against open surgeries
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Interventional Radiology – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Interventional Radiology  Market, By Imaging Modalities
   6.1. Fluoroscopy
   6.2. Computed tomography
   6.3. Ultrasound Injection
7. Interventional Radiology  Market, By Application
   7.1. Vascular
   7.2. Neurologic
   7.3. Spine
8. Interventional Radiology  Market, By Procedure
   8.1. Angiography
   8.2. Cholecystostomy
   8.3. Zmbolization
9. Interventional Radiology  Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Interventional Radiology – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   11.1. Lantheus Medical Imaging
   11.2. The Boston Scientific Corporation
   11.3. Baylis Medical Company
   11.4. Abott Laboratories
   11.5. Cordis Corporation
   11.6. Medtronic, Inc.
   11.7. St. Jude Medical, Inc
   11.8. Atlantis Worldwide
   11.9. Agilent Technologies
   11.10. NCD Company
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Expert Insights
Interventional radiology is the medical practice involving minimally invasive procedures in the diagnosis and treatment of various medical conditions as against complex and open surgical process. Interventional radiology procedures are performed with the aid of image guidance systems and includes various processes such as biopsies, cancerous/non-cancerous tumor removal and intravascular procedures. Globally decreasing popularity of the open surgical process is expected to be the key driving factor for interventional radiology during the period of study.

This report identifies the interventional radiology market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to interventional radiology market.
Interventional Radiology Market

Globally North America dominated the market for interventional radiology in 2015 with highest market share due to developed medical and healthcare establishment with latest healthcare equipment and best surgical practices in the world. North America was followed by Europe and Asia-Pacific as the second and third largest regional market respectively, for interventional radiology. However, Asia-Pacific is expected to be fastest growing regional segment during the period of study due to fast growing healthcare setup in the region especially in India and China along with growing awareness about the interventional radiology in the region.
  • This report on global interventional radiology segments global interventional radiology market on the basis of imaging modalities, application, procedures and market size in various geographical regions.
  • On the basis of imaging methods of the interventional radiology, this report is segmented into three major segments as follows: Fluoroscopy, Computed Tomography, and  Ultrasound
  •  This reports is also classified on the basis of application of interventional radiology, based on this global interventional radiology market is classified into three major application segments as follows: Vascular, Neurologic, and Spine
  • This reports is also classified on the basis of procedures of interventional radiology, based on this global interventional radiology market is classified into three major procedures segments as follows: Angiography, Cholecystostomy, and Zmbolization
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for interventional radiology  in each of the region.

This report identifies all the major companies operating in the global interventional radiology market. Some of the major companies’ profiles in detail are as follows:
  • Sanofi-pasteur
  • Novartis Inc.
  • GlaxoSmithKline
  • Abott Laboratories
  • Pfizer Inc.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports